Sept. 08, 2005 |
|
Dec. 17, 2018 |
|
jRCT2080220078 |
Phase III study of SUN Y7017 (memantine hydrochloride) in patients with moderately severe to severe dementia of the Alzheimer's type |
|
version: date: |
DAIICHI SANKYO Co.,Ltd. |
||
http://www.daiichisankyo.co.jp/contact/clinical/index.html |
||
Interventional |
||
double-blind, parallel-group, comparative study |
||
3 |
||
Patients whose age is 50 or higher and with a probable diagnosis of moderately severe to severe dementia of the Alzheimer's type according to the diagnostic criteria |
||
50age old over | ||
No limit | ||
Both |
||
moderately severe to severe dementia of the Alzheimer's type |
||
investigational material(s) |
||
Efficacy, Safety |
||
DAIICHISANKYO Co.,Ltd. | |
JapicCTI-050078 | |